The application leverages existing clinical data for Uzedy along with prior FDA findings on the safety of Udezy in patients ...

Legion Technologies, an innovator in workforce management, today announced it is working with Deckers Brands, parent company of UGG®, Koolaburra®, HOKA®, Teva®, and AHNU®, to better align the retailer ...

Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, president and chief executive ...

Yes, we know, it's still February and yet we can't stop going on about hiking sandals, but what can we say? Our toes are ...

Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries, and Medincell announced that the supplemental New Drug ...

The FDA has accepted a supplemental New Drug Application submitted by Teva (NYSE:TEVA) and Medincell (OTC:MDCLF) for Uzedy ...

Teva Pharmaceuticals (TEVA) and Medincell (MEDCL) announced that the supplemental New Drug Application sNDA for UZEDY extended-release ...

Backed by 40-plus years of experience, the new Grandview Max stakes it claim as this spring's open-toed outdoor overlord.

FYB203, a biosimilar to aflibercept, received UK MHRA approval for multiple retinal conditions and will be marketed as ...

Three ustekinumab biosimilars enter the US market, expanding access to more affordable options referencing Stelara ...

J&J Chief Financial Officer Joe Wolk has said the Stelara biosimilar market was likely to unfurl similarly to that of ...